Myeloma Behind the Scenes…ASH

Tiffany Williams |

My pre-ASH19 blog was titled the Magic of ASH, comparing ASH to the magic of Disney. As I reflect on my ASH 2019 experience, I once again am reminded of a Disney comparison. Disney Behind the Scenes is a 7-hour tour that gives customers the experience of learning what it takes to bring the magic […]

Cindy Chmielewski on ASH background

Immunotherapy – Front and Center

Cynthia Chmielewski |

Immunotherapy was front and center at this year’s American Society of Hematology’s (ASH) meeting. There even was an Education Session presented by Drs. Shah, Cohen and Borello on this topic. When I first attended the ASH Annual Meeting in 2012, immunotherapy was still in its infancy. The treatments that were being examined in clinical trials back […]

Monoclonal Antibodies Take ASH by Storm

Linda Huguelet |

Monoclonal antibodies are becoming the backbone of treatments for relapsed and refractory patients, but they are also making their way into the front-line setting for newly diagnosed patients. The first official day of the American Society of Hematology (ASH) Annual Conference was filled presentations, posters, and exhibits touting the effectiveness of this drug class. I would […]

ASH Is the Most Important Conference for Myeloma Patients and Doctors

Jack Aiello |

There is no other single conference where so much information is presented about myeloma. Information about so many topics is provided:  how to treat MM patients in various stages; results of phase II & III trials which may indicate upcoming FDA approvals; pre-clinical research focusing on myeloma targets and cell understanding; and more. Soon I’ll be […]

Cindy Chmielewski on ASH background

Through a Patient’s Eyes #ASH19 #MMSM

Cynthia Chmielewski |

In a few weeks I will be traveling to the Sunshine State to attend the 61st Annual Meeting of the American Society of Hematology (ASH#19) with the International Myeloma Foundation (IMF).  I am fortunate that the IMF understands the importance of patient education and the value of including the patient perspective at scientific meetings.  This […]